<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01316575</url>
  </required_header>
  <id_info>
    <org_study_id>ANES-3</org_study_id>
    <nct_id>NCT01316575</nct_id>
  </id_info>
  <brief_title>Prophylactic nCPAP Following Bowel Surgery (Bio-REB File 11-27)</brief_title>
  <official_title>Prophylactic Nasal Continuous Positive Airway Pressure (nCPAP) Following Bowel Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Saskatchewan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Royal University Hospital Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Saskatchewan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether prophylactic nasal continuous positive
      airway pressure (nCPAP) in the post-anaesthesia care unit (PACU) improves post-operative
      pulmonary function following elective bowel surgery. The investigators hypothesize that one
      hour of nCPAP in the PACU will result in a higher partial pressure of arterial oxygen (PaO2)
      when compared to the standard treatment of low flow oxygen applied by face mask.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-operative pulmonary complications, such as hypoxemia, pneumonia and respiratory failure,
      occur in 5-10% of patients following abdominal surgery. These post-operative pulmonary
      complications result in increased morbidity, mortality, ICU admission, length of hospital
      stay and resource use.

      CPAP has shown to be an effective treatment for hypoxemia following abdominal surgery. It
      decreases atelectasis formation the risk of pneumonia. Application of nCPAP to treat
      hypoxemic respiratory failure following thoraco-abdominal surgery has shown to decrease
      endotracheal intubation.

      Nasal CPAP has shown to be effective prophylaxis following elective cardiac and
      thoraco-abdominal aortic surgery. It reduces the incidence of hypoxemia, pneumonia,
      re-intubation and re-admission to the ICU. It has also shown to decrease the length of
      hospital stay.

      The use of nCPAP immediately post-operatively in the PACU following abdominal surgery has not
      been evaluated. Nasal CPAP is better tolerated than full face mask CPAP. It allows for
      effective clearance of respiratory secretions, improved communication and decreases
      claustrophobic sensation. The PACU is a transition period from general anaesthesia into the
      post-operative recovery phase. During this time, residual anaesthetic causes decreased level
      of consciousness and sub-optimal respiratory effort. Reversal agent for neuromuscular
      blockade has often not reached its peak effect. Inadequate pain control may further decrease
      respiratory effort. This transition period may be when maximal atelectasis of alveolar lung
      units occurs. This time period may be optimal for the application of nCPAP for prophylaxis
      against hypoxemia. It may improve post-operative pulmonary function which could decrease
      post-operative morbidity, mortality, length of hospital stay and resource use.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alveolar - Arterial Gradient</measure>
    <time_frame>1 hour following admission to PACU</time_frame>
    <description>Alveolar - arterial gradient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Requiring Reintubation</measure>
    <time_frame>Up to 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Requiring Admission to ICU</measure>
    <time_frame>Up to 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay in Hospital</measure>
    <time_frame>Up to 2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Postoperative Pulmonary Atelectasis</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>nCPAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group will receive nasal CPAP at 10cmH20 for one hour in the Post Anesthetic Care Unit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Flow Oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will receive standard therapy of low flow oxygen via simple mask at 8 litres per minute.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nCPAP</intervention_name>
    <description>The experimental group will receive nasal CPAP at 10cmH20 for one hour in the Post Anesthetic Care Unit.</description>
    <arm_group_label>nCPAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low Flow Oxygen</intervention_name>
    <description>The control group will receive standard therapy of low flow oxygen via simple mask at 8 litres per minute.</description>
    <arm_group_label>Low Flow Oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled to undergo elective laparotomy for bowel surgery

        Exclusion Criteria:

          -  age &lt; 18 years

          -  postoperative admission to the intensive care unit

          -  a history of allergy/intolerance to Ametop
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William P McKay, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <reference>
    <citation>Zarbock A, Mueller E, Netzer S, Gabriel A, Feindt P, Kindgen-Milles D. Prophylactic nasal continuous positive airway pressure following cardiac surgery protects from postoperative pulmonary complications: a prospective, randomized, controlled trial in 500 patients. Chest. 2009 May;135(5):1252-1259. doi: 10.1378/chest.08-1602. Epub 2008 Nov 18.</citation>
    <PMID>19017864</PMID>
  </reference>
  <reference>
    <citation>Ferreyra GP, Baussano I, Squadrone V, Richiardi L, Marchiaro G, Del Sorbo L, Mascia L, Merletti F, Ranieri VM. Continuous positive airway pressure for treatment of respiratory complications after abdominal surgery: a systematic review and meta-analysis. Ann Surg. 2008 Apr;247(4):617-26. doi: 10.1097/SLA.0b013e3181675829. Review.</citation>
    <PMID>18362624</PMID>
  </reference>
  <reference>
    <citation>Kindgen-Milles D, Müller E, Buhl R, Böhner H, Ritter D, Sandmann W, Tarnow J. Nasal-continuous positive airway pressure reduces pulmonary morbidity and length of hospital stay following thoracoabdominal aortic surgery. Chest. 2005 Aug;128(2):821-8.</citation>
    <PMID>16100174</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2011</study_first_submitted>
  <study_first_submitted_qc>March 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2011</study_first_posted>
  <results_first_submitted>July 20, 2012</results_first_submitted>
  <results_first_submitted_qc>January 22, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 27, 2013</results_first_posted>
  <last_update_submitted>January 22, 2013</last_update_submitted>
  <last_update_submitted_qc>January 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Saskatchewan</investigator_affiliation>
    <investigator_full_name>William McKay</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>Continuous Positive Airway Pressure</keyword>
  <keyword>Postoperative Complications</keyword>
  <keyword>Respiratory Insufficiency</keyword>
  <keyword>Colorectal Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Atelectasis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment began 4 April 2011 and ended 29 April 2012. The target enrollment was 40. 40 patients were enrolled in the study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>nCPAP</title>
          <description>The experimental group will receive nasal CPAP at 10cmH20 for one hour in the Post Anesthetic Care Unit.</description>
        </group>
        <group group_id="P2">
          <title>Low Flow Oxygen</title>
          <description>The control group will receive standard therapy of low flow oxygen via simple mask at 8 litres per minute.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Required alternate treatment</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>nCPAP</title>
          <description>The experimental group will receive nasal CPAP at 10cmH20 for one hour in the Post Anesthetic Care Unit.</description>
        </group>
        <group group_id="B2">
          <title>Low Flow Oxygen</title>
          <description>The control group will receive standard therapy of low flow oxygen via simple mask at 8 litres per minute.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63" spread="12"/>
                    <measurement group_id="B2" value="61" spread="11.4"/>
                    <measurement group_id="B3" value="62" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Alveolar - Arterial Gradient</title>
        <description>Alveolar - arterial gradient</description>
        <time_frame>1 hour following admission to PACU</time_frame>
        <population>From the literature, a sample size of 19 subjects per group is required for a power &gt;0.9 and alpha &lt;0.05 assuming a normalised difference in A-a gradient between groups of 0.33 and a Standard Deviation (SD) of 0.33</population>
        <group_list>
          <group group_id="O1">
            <title>nCPAP</title>
            <description>The experimental group will receive nasal CPAP at 10cmH20 for one hour in the Post Anesthetic Care Unit.</description>
          </group>
          <group group_id="O2">
            <title>Low Flow Oxygen</title>
            <description>The control group will receive standard therapy of low flow oxygen via simple mask at 8 litres per minute.</description>
          </group>
        </group_list>
        <measure>
          <title>Alveolar - Arterial Gradient</title>
          <description>Alveolar - arterial gradient</description>
          <population>From the literature, a sample size of 19 subjects per group is required for a power &gt;0.9 and alpha &lt;0.05 assuming a normalised difference in A-a gradient between groups of 0.33 and a Standard Deviation (SD) of 0.33</population>
          <units>torr</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.6" spread="28.3"/>
                    <measurement group_id="O2" value="134" spread="72.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Requiring Reintubation</title>
        <time_frame>Up to 2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>nCPAP</title>
            <description>The experimental group will receive nasal CPAP at 10cmH20 for one hour in the Post Anesthetic Care Unit.</description>
          </group>
          <group group_id="O2">
            <title>Low Flow Oxygen</title>
            <description>The control group will receive standard therapy of low flow oxygen via simple mask at 8 litres per minute.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Requiring Reintubation</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Requiring Admission to ICU</title>
        <time_frame>Up to 2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>nCPAP</title>
            <description>The experimental group will receive nasal CPAP at 10cmH20 for one hour in the Post Anesthetic Care Unit.</description>
          </group>
          <group group_id="O2">
            <title>Low Flow Oxygen</title>
            <description>The control group will receive standard therapy of low flow oxygen via simple mask at 8 litres per minute.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Requiring Admission to ICU</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay in Hospital</title>
        <time_frame>Up to 2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>nCPAP</title>
            <description>The experimental group will receive nasal CPAP at 10cmH20 for one hour in the Post Anesthetic Care Unit.</description>
          </group>
          <group group_id="O2">
            <title>Low Flow Oxygen</title>
            <description>The control group will receive standard therapy of low flow oxygen via simple mask at 8 litres per minute.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay in Hospital</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" spread="7.4"/>
                    <measurement group_id="O2" value="10.9" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>nCPAP</title>
        </group>
        <group group_id="E2">
          <title>Low Flow Oxygen</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>We made an assumption for FiO2, the respiratory quotient and barometric pressure in the alveolar air equation.
We did not standardize the time between extubation and application of nCPAP.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. William McKay</name_or_title>
      <organization>University of Saskatchewan</organization>
      <phone>306-655-1202</phone>
      <email>william.mckay@saskatoonhealthregion.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

